Invus Financial Advisors, LLC
New York, NY · CIK 1802978 · 13F filing filed 2022-08-15
SEC-registered investment adviser since 2012 · limited liability company
- Assets managed$16.5bn
- Staff70 · 43 in investment roles
- Main clients (by assets)Private funds 54%
- Private funds26 (4 hedge) · $8.9bn gross assets
- Form ADV · 2026-07-29SEC adviser record
- Kindhedge funds, private equity, futures
- Others nearbyNew York, NY
As an employer
- Offices in1 country
- Private fundsprivate equity 20, hedge 4, other private 2
$165.6m
reported value
-26.3% vs Q1 2022
8positions
100.0%in top 10
1 new
0 added
0 reduced
1 sold out
vs Q1 2022
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCUS BIOSCIENCES INC RCUS | $40.9m24.66% | Unchanged |
| COUPANG INC CPNG | $38.8m23.45% | Unchanged |
| NOVOCURE LTD NVCR | $24.4m14.72% | Unchanged |
| NU HLDGS LTD NU | $20.9m12.61% | New |
| TABOOLA.COM LTD TBLA | $19.8m11.94% | Unchanged |
| OYSTER PT PHARMA INC OYST | $12.0m7.24% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $4.5m2.73% | Unchanged |
| IONQ INC IONQ | $4.4m2.64% | Unchanged |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| DIDI GLOBAL INC DIDIY | $228.0k91.1k shares |